Calidi Biotherapeutics Inc.
13F holders, Q2 2024 (June 30)30holders −1
10new positions
11sold out
1famous investor
$0.19avg. 13F price*
At the end of Q2 2024, 30 institutions reported holding Calidi Biotherapeutics Inc. in their 13F filings, down 1 from Q1 2024. 10 opened new positions and 11 sold out. The largest holders were Red Wave Investments LLC ($125K), CPR Investments Inc. ($112K) and RS Crum Inc. ($53K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Calidi Biotherapeutics Inc.
- CUSIP
- 320703101
- Latest filing quarter
- Q2 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 10 | $60K |
| Exits | 11 | $529K |
All 13F filers, Q1 2024 → Q2 2024: 1,331,421 shares bought and 1,529,843 shares sold, net −198,422 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 30 holders
| Red Wave Investments LLC | 0.05% | Reduce -3.1% | 624,602 | $125K |
| CPR Investments Inc. | 0.09% | Add +700.0% | 560,000 | $112K |
| RS Crum Inc. | 0.01% | Add +2327.4% | 263,470 | $53K |
| Delta Investment Management, LLC | 0.01% | Add +1955.0% | 210,230 | $42K |
| Citadel Advisors | 0.00% | New | 125,905 | $25K |
| Finepoint Capital LP | 0.01% | No change | 125,000 | $25K |
| HRT Financial LP | 0.00% | Add +620.6% | 101,390 | $20K |
| Polar Asset Management Partners Inc. | 0.00% | No change | 125,000 | $13K |
| Highbridge Capital Management LLC | 0.00% | New | 62,500 | $13K |
| Governors Lane LP | 0.00% | Reduce -50.0% | 47,349 | $9K |
| XTX Topco Ltd | 0.00% | New | 42,964 | $9K |
| 683 Capital Management, LLC | 0.00% | Reduce -21.1% | 37,879 | $8K |
| Magnetar Financial LLC | 0.00% | Reduce -46.7% | 33,638 | $6K |
| Virtu Financial LLC | 0.00% | Reduce -38.3% | 25,965 | $5K |
| DLK Investment Management, LLC | 0.00% | New | 20,812 | $4K |
| Morgan Stanley | 0.00% | No change | 19,187 | $4K |
| Vanguard Group Inc. | 0.00% | No change | 14,939 | $3K |
| State Street Corp. | 0.00% | New | 12,900 | $3K |
| Cable Car Capital, LP | 0.00% | Reduce -97.6% | 11,277 | $2K |
| Two Sigma Securities, LLC | 0.00% | New | 11,132 | $2K |
| Financial Counselors Inc. | 0.00% | New | 10,000 | $2K |
| Creative Planning | 0.00% | No change | 10,000 | $2K |
| Cetera Investment Advisers | 0.00% | New | 10,000 | $2K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -52.4% | 8,422 | $2K |
| CVA Family Office, LLC | 0.00% | New | 5,000 | $1K |
| BlackRock Inc. | 0.00% | No change | 2,588 | $518 |
| Osaic Holdings, Inc. | 0.00% | No change | 2,525 | $505 |
| Bank of America Corp. | 0.00% | New | 273 | $55 |
| PNC Financial Services Group, Inc. | 0.00% | No change | 100 | $20 |
| UBS Group AG | 0.00% | No change | 10 | $2 |
"% of holder's portfolio" is CALIDI BIOTHERAPEUTICS INC's weight in each manager's 13F, not the share of Calidi Biotherapeutics Inc. the manager owns.